The epidemiology of acquired immunodeficiency syndrome malignancies.
about
Human herpesvirus 8--a novel human pathogenAdoptive T cell therapy for cancer in the clinicThe viral etiology of AIDS-associated malignanciesNon-AIDS definings malignancies among human immunodeficiency virus-positive subjects: Epidemiology and outcome after two decades of HAART eraNovel immunotherapeutic strategies of gastric cancer treatmentSafety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi's sarcoma.An epidemiological analysis of potential associations between C-reactive protein, inflammation, and prostate cancer in the male US population using the 2009-2010 National Health and Nutrition Examination Survey (NHANES) data.Communication between the active sites and dimer interface of a herpesvirus protease revealed by a transition-state inhibitor.Growth regulation of simian and human AIDS-related non-Hodgkin's lymphoma cell lines by TGF-beta1 and IL-6.Role of the ubiquitin system and tumor viruses in AIDS-related cancer.A candidate gene approach for virally induced cancer with application to HIV-related Kaposi's sarcoma.Molecular biology of KSHV in relation to AIDS-associated oncogenesis.Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034Recreational amphetamine use and risk of HIV-related non-Hodgkin lymphoma.Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseasesEpstein-Barr Viral Load is Associated to Response in AIDS-Related Lymphomas.SNP screening of central MHC-identified HLA-DMB as a candidate susceptibility gene for HIV-related Kaposi's sarcomaSelective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection.Measurement of CD4+ T cells in point-of-care settings with the Sysmex pocH-100i haematological analyserMolecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.Local tumor control and toxicity in HIV-associated anal carcinoma treated with radiotherapy in the era of antiretroviral therapy.Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesisT cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology.Phosphoproteomic Analysis of KSHV-Infected Cells Reveals Roles of ORF45-Activated RSK during Lytic ReplicationVaccination history and risk of non-Hodgkin lymphoma: a population-based, case-control study.Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS.Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesisIdentification of mitochondrial genome concatemers in AIDS-associated lymphomas and lymphoid cell lines.Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat.Evolving spectrum and incidence of non-AIDS-defining malignancies.Anal squamous intraepithelial lesions among HIV positive and HIV negative men who have sex with men in Thailand.Classification of AIDS-related lymphoma cases between 1987 and 2012 in Japan based on the WHO classification of lymphomas, fourth edition.Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years.Cancer stem cell immunology: key to understanding tumorigenesis and tumor immune escape?Kaposi's sarcoma-associated herpesvirus transactivator RTA promotes degradation of the repressors to regulate viral lytic replication.Head and Neck Lymphomas in HIV Patients: a Clinical Perspective.Primary monophasic synovial sarcoma of the conjunctiva.
P2860
Q24530670-733FAD6F-783D-45BD-B870-CEA43E3D982BQ24680405-D40BFC8C-483B-4323-91BA-1092A2407930Q24685892-A0729594-2083-45B2-B0D9-5D3DF785E5B1Q26797897-E3162100-61B5-4950-88E1-8631D8B97B82Q27011232-8516D523-92CF-4683-9A24-57215D99CDE4Q30380999-4BDF2C78-3341-49AB-B168-8CAB6F449CCAQ30994067-931CA242-AB38-442F-A94B-3C62B6AD39BFQ33202465-1E7865D6-7849-44B7-B82C-7A8FEBAEEE5BQ33275612-A176FC96-3ACF-486E-80AB-062FF2046326Q33307881-7638F3D6-5699-4A94-A8F9-95A5CE3675A4Q33554898-C98BDBCC-1709-4683-AFA3-782F015FB681Q33560572-B3661BD3-1030-4245-8563-FDF96C597E23Q33561185-FA36C020-8D21-47E0-ACE4-EC069C3A19B6Q33822624-1F17DC68-E283-4A83-B1F6-2B01DA8B32CEQ33906970-0806D703-BB6B-4B6F-BD6B-C424B4EDF2DAQ33969513-5D4658D3-D75C-4006-B81E-049A6AEF98DEQ34240359-0136483D-0C5F-4327-B6BF-45F2D4327D33Q34342894-DB74601F-350B-4C22-99DE-2C99AEAF9CB7Q34406756-6652ABF5-C2FA-41DD-A8B8-6EC0C7E222F7Q35026060-E604AE03-C737-4834-B730-3BB6D72B8EAAQ35039830-49B27D56-E4A7-4AAF-9356-8FD76DD9E695Q35124404-13BCF1F6-DA12-417D-A0DE-F8E7A7BA26C5Q35550879-0FB0C2B1-81A0-4DF5-A35B-74E620E2E61AQ35680401-95694DC9-4A04-4221-9883-5F1626F4B945Q36244951-7F91E084-E551-4A5F-A87E-59E23B70DFB7Q36612286-2E643004-0B9F-48BC-8E8E-C2AAF3AD16BFQ36882284-D66E49E4-1412-4076-903A-083A343D8C20Q37314450-F4F46156-D818-4BD1-B8DF-30E55D18E806Q37348840-4874D585-C779-41B8-8214-C05FA03F2AC2Q37353390-321BF35E-04EA-43F8-A868-9C962AC2FB1FQ37419684-B8A0A1BB-C59B-4458-B886-A5B70B310456Q37595265-81BE82BB-2706-410A-BF5C-E839BA6D9349Q37837963-32EF7787-5696-4137-B4B5-BAF71E95BDA2Q38239661-DDD53F09-C4E0-4ABE-AE4A-A45FB6D8EE00Q40021229-BE0E6240-63A7-47F0-9D8C-28BA8741F828Q41919568-269E36AE-806F-4B24-A6B0-756869C04632Q43009129-EC872DEC-9A62-435B-B3E0-5F21DD6031D3
P2860
The epidemiology of acquired immunodeficiency syndrome malignancies.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
The epidemiology of acquired immunodeficiency syndrome malignancies.
@ast
The epidemiology of acquired immunodeficiency syndrome malignancies.
@en
The epidemiology of acquired immunodeficiency syndrome malignancies.
@nl
type
label
The epidemiology of acquired immunodeficiency syndrome malignancies.
@ast
The epidemiology of acquired immunodeficiency syndrome malignancies.
@en
The epidemiology of acquired immunodeficiency syndrome malignancies.
@nl
prefLabel
The epidemiology of acquired immunodeficiency syndrome malignancies.
@ast
The epidemiology of acquired immunodeficiency syndrome malignancies.
@en
The epidemiology of acquired immunodeficiency syndrome malignancies.
@nl
P1433
P1476
The epidemiology of acquired immunodeficiency syndrome malignancies.
@en
P2093
Goedert JJ
P304
P577
2000-08-01T00:00:00Z